🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is an open label Phase II study to evaluate the safety and effic...
Status
Active Not Recruiting
Location
Washington University
Start Date
2023-03-03
Trial ID
NCT05676034
Treatments Being Tested
The study is a randomized, double-blind, parallel-group clinical trial to e...
Status
Recruiting
Location
University of Washington Medicine Diabetes Institute (UWMDI)
Start Date
2026-06
Trial ID
NCT07699380
The primary objective is to evaluate the safety and tolerability of AMX0035...
Status
Completed
Location
University Hospitals Leuven
Start Date
2022-12-29
Trial ID
NCT05619783
Treatments Being Tested
The study is a 24-week, randomized, double-blind, multi-site, placebo-contr...
Status
Completed
Location
Clinical Neuroscience Solutions, Inc. - Jacksonville
Start Date
2018-09-14
Trial ID
NCT03533257
The Phoenix Trial is a randomized double blind placebo controlled Phase III...
Status
Active Not Recruiting
Location
Barrow Neurological Institute
Start Date
2021-10-28
Trial ID
NCT05021536
The CENTAUR trial was a 2:1 (active:placebo) randomized, double-blind, plac...
Status
Completed
Location
Barrow Neurological Institute
Start Date
2017-06-22
Trial ID
NCT03127514
The purpose of this study is to evaluate the pharmacokinetic and pharmacody...
Status
Unknown
Location
Norman Fixel Institute for Neurological Diseases
Start Date
2021-08-05
Trial ID
NCT04987671
Treatments Being Tested
A35-009 (ORION) is a Phase 2b/3 trial to evaluate the efficacy and safety o...
Status
Completed
Location
Mayo Clinic
Start Date
2023-12-21
Trial ID
NCT06122662
This extension study, in which all participants received active treatment (...
Status
Completed
Location
Barrow Neurological Institute-Dignity Health, St Joseph's Hospital and Medical Center
Start Date
2018-03-29
Trial ID
NCT03488524
Treatments Being Tested
The protocol is intended to provide extended treatment with AMX0035 to pati...
Status
Completed
Location
Forbes Norris MDA/ALS Research Center - California Pacific Medical Center
Start Date
2020-11-22
Trial ID
NCT04516096
Treatments Being Tested